A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome C Odiatis, I Savva, M Pieri, P Ioannou, P Petrou, G Papagregoriou, ... Matrix biology plus 9, 100053, 2021 | 7 | 2021 |
# 5441 EVIDENCE THAT CHAPERONE 4-PBA TREATMENT ALLEVIATES THE RENAL PHENOTYPE IN ALPORT SYNDROME MOUSE MODELS P Ioannou, C Odiatis, K Antoniadou, M Pieri, G Papagregoriou, A Malatras, ... Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_5441, 2023 | | 2023 |
Preclinical studies on Alport Syndrome mice treated with chemical chaperons P Ioannou, C Odiatis, A Malatras, K Antoniadou, M Pieri, G Papagregoriou, ... EUROPEAN JOURNAL OF HUMAN GENETICS 30 (SUPPL 1), 327-327, 2022 | | 2022 |
FP070 PHENOTYPIC ANALYSIS OF TWO ALPORT SYNDROME MODEL MICE WITH A COL4Α3 G1332E MUTATION C Odiatis, I Savva, M Pieri, P Ioannou, G Papagregoriou, N Makrides, ... Nephrology Dialysis Transplantation 34 (Supplement_1), gfz106. FP070, 2019 | | 2019 |